Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.
about
Side effects associated with current and prospective antimigraine pharmacotherapies.Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis
P2860
Heteroreceptors Modulating CGRP Release at Neurovascular Junction: Potential Therapeutic Implications on Some Vascular-Related Diseases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Heteroreceptors Modulating CGR ...... ome Vascular-Related Diseases.
@en
type
label
Heteroreceptors Modulating CGR ...... ome Vascular-Related Diseases.
@en
prefLabel
Heteroreceptors Modulating CGR ...... ome Vascular-Related Diseases.
@en
P2860
P50
P921
P356
P1476
Heteroreceptors Modulating CGR ...... ome Vascular-Related Diseases.
@en
P2093
Carlos M Villalón
Martha B Ramírez-Rosas
P2860
P304
P356
10.1155/2016/2056786
P407
P50
P577
2016-12-27T00:00:00Z